CD8A and cirrhosis of liver: Patients with high levels of CD8+ T lymphocytes benefited from increased DFS/RFS based on the percentage of males (≥80%; HR = 0.64; 95% CI, 0.45–0.91), percentage of patients with liver cirrhosis (≥80%; HR = 0.77; 95% CI, 0.61–0.88), percentage of patients with multiple tumors (<30%; HR = 0.43; 95% CI, 0.19–0.93), and the percentage of vascular invasion (<50%; HR = 0.70; 95% CI, 0.57–0.86).